Moderna stock slides 14% premarket after profit and revenue fall short of estimates and biotech offers soft guidance
Moderna Inc. shares MRNA, -3.88% slid 14% in premarket trade Thursday, after the COVID vaccine…
Read MoreModerna Inc. shares MRNA, -3.88% slid 14% in premarket trade Thursday, after the COVID vaccine…
Read MoreStellantis NV STLA, -0.42% on Thursday confirmed full-year targets after revenue increased on higher volumes…
Read MoreING Groep NV said Thursday that its third-quarter net profit ticked down on year, hit…
Read MoreZalando SE confirmed its targets for the year after posting higher revenue for the third…
Read MoreTupperware Brands Corp.’s stock TUP, fell a sharp 27.7% in premarket trades on Wednesday after…
Read MoreShares of Paramount Global PARA, +4.64% were falling more than 6% in premarket trading Wednesday…
Read MoreShares of Match Group Inc. rose more than 10% in after-hours trading Tuesday after the…
Read MoreUber Technologies Inc. stock rose sharply Tuesday morning as the company’s third-quarter revenue climbed 73%…
Read MoreVolkswagen AG on Friday backed the outlook for its full-year margin after operating profit and…
Read MoreDuring a month usually known for a lull in the sports calendar, American sportsbooks still…
Read More